bcbs federal glp 1 coverage GLP-1 for obesity treatment in 13 US states' Medicaid programs bcbs fep glp 1 coverage

The GLP-1 Gold Rush: Efficacy Meets Exorbitant Costs GLP-1 medications have demonstrated remarkable efficacy in treating type 2 diabetes and obesity, leading to significant weight loss in many patients

When to discuss a dose increase If you have been at your current dose for four or more weeks with minimal appetite suppression or weight change, a dose increase is usually the appropriate next step

As the use of GLP-1 therapies continues to expand, recognition of emerging safety signals in real-world data may support earlier clinical awareness, while formal causality determination remains the responsibility of marketing authorization holders and regulatory authorities

Thyroid tumors: Some GLP-1 medications carry a warning about a potential risk of thyroid C-cell tumors

"Novo Sees Generic Ozempic Delayed in China Until Next Year", SWI swissinfo , 6 May 2026, archived from the original on 29 May 2026 "Drugmaker seeks approval for China's first biosimilar Ozempic"